# Safety Study of a Topical Treatment for Dry Age Related Macular Degeneration

> **NCT01922128** · PHASE1 · COMPLETED · sponsor: **MacuCLEAR, Inc.** · enrollment: 20 (actual)

## Conditions studied

- Nonexudative Age-related Macular Degeneration

## Interventions

- **DRUG:** MC-1101, Placebo

## Key facts

- **NCT ID:** NCT01922128
- **Lead sponsor:** MacuCLEAR, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2013-11
- **Final completion:** 2013-12
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2014-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01922128

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01922128, "Safety Study of a Topical Treatment for Dry Age Related Macular Degeneration". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01922128. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*